Background

Dr. Richard F. Borch M.D., serves as the Chairman of Medical Chemistry and Molecular Pharmacology at the School of Pharmacy and Pharmaceutical Sciences. He serves as a Member of Scientific Advisory Board at MediQuest Therapeutics, Inc. He serves as a Director of the Purdue University Cancer Center. Dr. Borch's research interests include: chemical approaches to the selective reduction of toxicity of anticancer drugs, modulation of anticancer drug-induced hematologic toxicity, ... pharmacologic induction of cytokines, reduction of drug-induced myelosuppression, and synthesis of mechanism-based phosphoramidates as novel anticancer agents. Dr. Borch headed the clinical development laboratory at the University of Rochester and was responsible for drug candidate testing. He graduated with honors from Stanford University with a B.S. in Chemistry and obtained his Ph.D. in Chemistry from Columbia University. He was a Postdoctoral Fellow at Harvard and received his M.D. in Internal Medicine from the University of Minnesota.

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.